Form 4: Modular Medical Director Acquires Stock Options

Sentiment:

Insider Transaction Report


Ellen O'Connor Vos, a Director at Modular Medical, Inc., acquired stock options as part of the company's Outside Director Compensation Plan.

Summary

  • Ellen O'Connor Vos, a Director of Modular Medical, Inc., was granted stock options on March 31, 2026.
  • The options have an exercise price of $4.55 and are exercisable immediately.
  • The total number of shares underlying these options is 250.
  • These options are part of the Issuer's Outside Director Compensation Plan and are fully vested.
  • The reporting person's beneficial ownership of this class of derivative security is 250 options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director as part of a compensation plan, with no immediate indication of significant positive or negative company performance.

Positives

  • Director Ellen O'Connor Vos received stock options, indicating continued alignment with the company's performance.
  • The options are fully vested and immediately exercisable, providing direct benefit to the director.
  • The transaction is part of a structured compensation plan for outside directors.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock option grant.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and medical device sectors to incentivize long-term performance and align executive interests with shareholders.

Stakeholder Impact

  • Shareholders: The grant of options to a director aligns their interests with shareholders, potentially encouraging actions that benefit the company's stock value.

Key Dates

DateDescription
03/31/2026Date of earliest transaction / Grant date of stock options
04/08/2026Date of filing of Form 4

Keywords

stock options, director compensation, Modular Medical, MODD, SEC Form 4, insider trading, equity award

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.